Eli Lilly and its subsidiary, Avid Radiopharmaceuticals, have announced that the European Commission has approved Amyvid (Florbetapir (18F)) solution for injection as a diagnostic radiopharmaceutical.
C. Joseph Ross Daval, Brigham and Women’s Hospital and Harvard University, Boston, Massachusetts. Ameet Sarpatwari, Brigham and Women’s Hospital and Harvard University. Aaron S. Kesselheim ([email ...
Background and objective Amyloid-positron emission tomography (PET) imaging (API) detects amyloid-beta pathology early in the course of Alzheimer’s disease (AD) with high sensitivity and specificity. ...
This chapter traces the field’s evolution, in parallel with advances in biomarkers, from the 1984 NINCDS–ADRDA clinical-only criteria to the 2011 NIA–AA biomarker-informed updates, the 2018 research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results